Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2004-7-29
pubmed:abstractText
The development of tolerance following the use of long acting beta(2) agonists in asthmatic patients with either the homozygous arginine (Arg-16) or glycine (Gly-16) genotypes is poorly documented, especially in relation to the acute reliever response to salbutamol in constricted airways. A study was undertaken to evaluate the Arg-16 and Gly-16 genotypes for the acute salbutamol response following methacholine bronchial challenge between the first and last doses of formoterol (FM) and salmeterol (SM) combination inhalers.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10329815, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10340917, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10492055, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10903223, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10936119, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10950895, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-10984540, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-11413351, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-11586955, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-12016095, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-14651722, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-7597661, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-7598936, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-7616798, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-7901205, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-7913292, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-8100652, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-8635376, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-8658370, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-9329515, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-9358137, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-9399966, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-9641570, http://linkedlifedata.com/resource/pubmed/commentcorrection/15282385-9893190
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0040-6376
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
662-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15282385-Adrenergic beta-Agonists, pubmed-meshheading:15282385-Adult, pubmed-meshheading:15282385-Aged, pubmed-meshheading:15282385-Albuterol, pubmed-meshheading:15282385-Asthma, pubmed-meshheading:15282385-Bronchodilator Agents, pubmed-meshheading:15282385-Cross-Over Studies, pubmed-meshheading:15282385-Double-Blind Method, pubmed-meshheading:15282385-Drug Tolerance, pubmed-meshheading:15282385-Ethanolamines, pubmed-meshheading:15282385-Female, pubmed-meshheading:15282385-Forced Expiratory Volume, pubmed-meshheading:15282385-Genotype, pubmed-meshheading:15282385-Homozygote, pubmed-meshheading:15282385-Humans, pubmed-meshheading:15282385-Male, pubmed-meshheading:15282385-Middle Aged, pubmed-meshheading:15282385-Peak Expiratory Flow Rate, pubmed-meshheading:15282385-Receptors, Adrenergic, beta-2
pubmed:year
2004
pubmed:articleTitle
Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
pubmed:affiliation
Asthma and Allergy Research Group, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't